Expert initiative for the prevention and control of human papillomavirus infection and related diseases among Chinese males.
10.3760/cma.j.cn112150-20250724-00712
- Collective Name:Committee for Travel Health, Chinese Preventive Medicine Association;Committee for Vaccine and Health, China Health Culture Association
- Publication Type:Journal Article
- MeSH:
Humans;
Papillomavirus Infections/prevention & control*;
Male;
Papillomavirus Vaccines;
China;
Vaccination;
East Asian People
- From:
Chinese Journal of Preventive Medicine
2025;59(10):1611-1619
- CountryChina
- Language:Chinese
-
Abstract:
Human papillomavirus (HPV) infection not only causes cervical cancer in women but also leads to HPV-related cancers and genital warts in men. Globally, 82 countries have adopted a gender-neutral HPV vaccination strategy to prevent and control related diseases. In China, HPV vaccination for men has now been implemented. Based on the global and domestic burden of male HPV-related diseases, evidence on the safety and efficacy of HPV vaccines in males, and lessons from international male HPV prevention efforts, a panel of experts has developed the Expert Initiative for the Prevention and Control of HPV Infection and related diseases among Chinese males after multi-round discussions. The initiative proposes: Develop comprehensive strategies for the prevention and control of male HPV infection and related diseases; prioritize and enhance public education and awareness campaigns; promote joint prevention for both men and women and advance gender-inclusive vaccination; innovate financing mechanisms to reduce the economic burden; strengthen research on male HPV infection and vaccination to facilitate the development of new vaccines; and adopt innovative immunization models to improve the quality of vaccination services.
